@article{3106119,
    title = "Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: Myeloma response assessment and diagnosis system (MY-RADS)",
    author = "Messiou, C. and Hillengass, J. and Delorme, S. and Lecouvet, F.E. and Moulopoulos, L.A. and Collins, D.J. and Blackledge, M.D. and Abildgaard, N. and Østergaard, B. and Schlemmer, H.-P. and Landgren, O. and Asmussen, J.T. and Kaiser, M.F. and Padhani, A.",
    journal = "Dentomaxillofacial Radiology",
    year = "2019",
    volume = "291",
    number = "1",
    pages = "5-13",
    publisher = "Radiological Society of North America Inc.",
    doi = "10.1148/radiol.2019181949",
    keywords = "allogeneic stem cell transplantation;  Article;  body movement;  bone marrow cell;  cancer size;  clinical assessment;  computer assisted diagnosis;  diagnostic procedure;  human;  information processing;  myeloma;  myeloma cell;  practice guideline;  priority journal;  radiologist;  whole body MRI;  consensus;  information processing;  methodology;  multiple myeloma;  nuclear magnetic resonance imaging;  procedures;  whole body imaging, Consensus;  Data Collection;  Humans;  Magnetic Resonance Imaging;  Multiple Myeloma;  Practice Guidelines as Topic;  Research Design;  Whole Body Imaging",
    abstract = "Acknowledging the increasingly important role of whole-body MRI for directing patient care in myeloma, a multidisciplinary, international, and expert panel of radiologists, medical physicists, and hematologists with specific expertise in whole-body MRI in myeloma convened to discuss the technical performance standards, merits, and limitations of currently available imaging methods. Following guidance from the International Myeloma Working Group and the National Institute for Clinical Excellence in the United Kingdom, the Myeloma Response Assessment and Diagnosis System (or MY-RADS) imaging recommendations are designed to promote standardization and diminish variations in the acquisition, interpretation, and reporting of whole-body MRI in myeloma and allow response assessment. This consensus proposes a core clinical protocol for whole-body MRI and an extended protocol for advanced assessments. © 2019 Radiological Society of North America Inc.. All rights reserved."
}